Esperion Therapeutics Inc (ESPR): Next-Year EPS Estimate 779.17%
As of 2026-06-04, Esperion Therapeutics Inc (ESPR) has a next-year EPS growth estimate of 779.17%.
On 2026-05-13, analyst consensus for ESPR's next-year EPS growth shifted from 1257.16% to 779.17% — a negative change of 477.99 percentage points. The revised estimate has been sustained across 17 subsequent trading sessions. Current-year growth is projected at 63.64%.
Current Snapshot
- Sector
- Healthcare
- Industry
- Drug Manufacturers - Specialty & Generic
- EPS growth next year
- 779.17%
- EPS growth this year
- 63.64%
- EPS next quarter (est)
- $0.00
- Last price
- $3.13
EPS Revision History
| Date | EPS Next Y | EPS This Y | Next Q (est) | Price |
|---|---|---|---|---|
| 2026-06-04 | 779.17% | 63.64% | $0.00 | $3.13 |
| 2026-06-03 | 779.17% | 63.64% | $0.00 | $3.14 |
| 2026-06-02 | 779.17% | 63.64% | $0.00 | $3.14 |
| 2026-06-01 | 779.17% | 63.64% | $0.00 | $3.13 |
| 2026-05-31 | 779.17% | 63.64% | $0.00 | $3.13 |
| 2026-05-28 | 779.17% | 63.64% | $0.00 | $3.13 |
| 2026-05-27 | 779.17% | 63.64% | $0.00 | $3.13 |
| 2026-05-26 | 779.17% | 63.64% | $0.00 | $3.12 |
| 2026-05-25 | 779.17% | 63.64% | $0.00 | $3.13 |
| 2026-05-24 | 779.17% | 63.64% | $0.00 | $3.13 |
| 2026-05-21 | 779.17% | 63.64% | $0.00 | $3.13 |
| 2026-05-20 | 779.17% | 63.64% | $0.00 | $3.13 |
| 2026-05-19 | 779.17% | 63.64% | $0.00 | $3.13 |
| 2026-05-18 | 779.17% | 63.64% | $0.00 | $3.13 |
| 2026-05-17 | 779.17% | 63.64% | $0.00 | $3.12 |
| 2026-05-14 | 779.17% | 63.64% | $0.00 | $3.12 |
| 2026-05-13 | 779.17% | 63.64% | $0.00 | $3.12 |
| 2026-05-12 | 1257.16% | 78.79% | $0.00 | $3.13 |
| 2026-05-11 | 1257.16% | 78.79% | $0.00 | $3.13 |
| 2026-05-10 | 778.01% | 69.70% | $0.00 | $3.14 |
| 2026-05-07 | 778.01% | 69.70% | -$0.04 | $3.14 |
| 2026-05-06 | 778.01% | 69.70% | -$0.04 | $3.15 |
| 2026-05-05 | 778.01% | 69.70% | -$0.04 | $3.12 |
| 2026-05-04 | 769.66% | 69.23% | -$0.04 | $3.12 |
| 2026-05-03 | 769.66% | 69.23% | -$0.04 | $3.11 |
| 2026-04-30 | 910.09% | 92.83% | -$0.03 | $2.00 |
| 2026-04-29 | 910.09% | 92.83% | -$0.03 | $1.91 |
| 2026-04-28 | 910.09% | 92.83% | -$0.03 | $1.91 |
| 2026-04-27 | 910.09% | 92.83% | -$0.03 | $1.91 |
| 2026-04-26 | 910.09% | 92.83% | -$0.03 | $1.91 |
Recent News
Screen Performance
Aggregate stats across all 1761 tickers our top-EPS-revision screen has flagged over the past 64 days.
- Median return since detection
- +5.1%
- % of tickers in the green
- 62%
- Median return on winners
- +17.5%
- Large revisions captured
- 746
Past detection performance reflects the price change between when a ticker first entered our screen and the most recent observation. Not a forward-looking forecast.
Frequently Asked Questions
What is Esperion Therapeutics Inc's next-year EPS growth estimate?▾
As of 2026-06-04, Esperion Therapeutics Inc (ESPR) has a next-year EPS growth estimate of 779.17%, based on analyst consensus.
When was the latest EPS estimate revision for ESPR?▾
The most recent revision occurred on 2026-05-13, when analysts adjusted the next-year EPS growth estimate from 1257.16% to 779.17%.
What sector and industry does Esperion Therapeutics Inc belong to?▾
Esperion Therapeutics Inc operates in the Healthcare sector, specifically the Drug Manufacturers - Specialty & Generic industry.
How often is this EPS estimate data updated?▾
EPS revision data is refreshed daily from analyst consensus estimates. ESPR appears on this page because it was flagged by our daily top-EPS-revision-performer screen.
EPS revision data sourced from analyst consensus estimates, refreshed daily. Esperion Therapeutics Inc (ESPR) appears here because it was detected by our daily top-EPS-revision-performer screen.
← All reports